Results for tag: "Psoriasis Pipeline"

The Psoriasis Pipeline market is a segment of the pharmaceutical industry focused on the development of drugs to treat psoriasis. Psoriasis is a chronic, inflammatory skin condition that affects millions of people worldwide. The pipeline market is composed of a variety of drug candidates in various stages of development, from pre-clinical to late-stage clinical trials. These drugs are designed to target the underlying causes of psoriasis, such as inflammation, immune system dysfunction, and genetic factors. The Psoriasis Pipeline market is highly competitive, with many companies vying for a share of the market. Companies in the market include AbbVie, Amgen, Celgene, Eli Lilly, Janssen, Novartis, Pfizer, and Regeneron. These companies are actively researching and developing new treatments for psoriasis, with the goal of providing more effective and affordable treatments for patients. Show Less Read more